JOHN JOHNSON - 02 Jul 2021 Form 4 Insider Report for Strongbridge Biopharma plc

Role
Chief Executive Officer, Director
Signature
/s/ Judith Goldberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
02 Jul 2021
Net transactions value
-$156,670
Form type
4
Filing time
07 Jul 2021, 17:01:44 UTC
Previous filing
30 Jun 2021
Next filing
21 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBBP Ordinary Shares Tax liability $156,670 -50,867 -5.1% $3.08 944,960 02 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.